A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease globally, and represents a health care burden as treatment options are very scarce. The reason behind the NAFLD progression to non-alcoholic steatohepatitis (NASH) is not completely understood. Recently, the deficiency o...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/13/2/652 |
_version_ | 1797396277639512064 |
---|---|
author | Moris Sangineto Vidyasagar Naik Bukke Francesco Bellanti Rosanna Tamborra Archana Moola Loren Duda Rosanna Villani Antonino Davide Romano Gaetano Serviddio |
author_facet | Moris Sangineto Vidyasagar Naik Bukke Francesco Bellanti Rosanna Tamborra Archana Moola Loren Duda Rosanna Villani Antonino Davide Romano Gaetano Serviddio |
author_sort | Moris Sangineto |
collection | DOAJ |
description | Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease globally, and represents a health care burden as treatment options are very scarce. The reason behind the NAFLD progression to non-alcoholic steatohepatitis (NASH) is not completely understood. Recently, the deficiency of micronutrients (e.g., vitamins, minerals, and other elements) has been suggested as crucial in NAFLD progression, such that recent studies reported the potential hepatic antioxidant properties of micronutrients supplementation. However, very little is known. Here we have explored the potential beneficial effects of dietary supplementation with FLINAX, a novel mixture of nutraceuticals (i.e., vitamin E, vitamin D3, olive dry-extract, cinnamon dry-extract and fish oil) in a NAFLD model characterized by oxidative stress and mitochondrial function impairment. Steatosis was firstly induced in Wistar rats by feeding with a high-fat/high-cholesterol diet for 4 weeks, and following this the rats were divided into two groups. One group (n = 8) was treated for 2 weeks with a normal chow-diet, while a second group (n = 8) was fed with a chow-diet supplemented with 2% FLINAX. Along with the entire experiment (6 weeks), a third group of rats was fed with a chow-diet only as control. Statistical analysis was performed with Student’s T test or one-way ANOVA followed by post-hoc Bonferroni test when appropriate. Steatosis, oxidative stress and mitochondrial respiratory chain (RC) complexes activity were analyzed in liver tissues. The dietary supplementation with FLINAX significantly improved hepatic steatosis and lipid accumulation compared to untreated rats. The mRNA and protein levels analysis showed that <i>CPT1A</i> and <i>CPT2</i> were up-regulated by FLINAX, suggesting the enhancement of fatty acids oxidation (FAO). Important lipoperoxidation markers (i.e., HNE- and MDA-protein adducts) and the quantity of total mitochondrial oxidized proteins were significantly lower in FLINAX-treated rats. Intriguingly, FLINAX restored the mitochondrial function, stimulating the activity of mitochondrial RC complexes (i.e., I, II, III and ATP-synthase) and counteracting the peroxide production from pyruvate/malate (complex I) and succinate (complex II). Therefore, the supplementation with FLINAX reprogrammed the cellular energy homeostasis by restoring the efficiency of mitochondrial function, with a consequent improvement in steatosis. |
first_indexed | 2024-03-09T00:49:02Z |
format | Article |
id | doaj.art-d70507bf5cf34ef88f713245640e950f |
institution | Directory Open Access Journal |
issn | 2072-6643 |
language | English |
last_indexed | 2024-03-09T00:49:02Z |
publishDate | 2021-02-01 |
publisher | MDPI AG |
record_format | Article |
series | Nutrients |
spelling | doaj.art-d70507bf5cf34ef88f713245640e950f2023-12-11T17:21:36ZengMDPI AGNutrients2072-66432021-02-0113265210.3390/nu13020652A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD ModelMoris Sangineto0Vidyasagar Naik Bukke1Francesco Bellanti2Rosanna Tamborra3Archana Moola4Loren Duda5Rosanna Villani6Antonino Davide Romano7Gaetano Serviddio8C.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyC.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyInternal Medicine, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyC.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyC.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyPathology Unit, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, ItalyC.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyC.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyC.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyNon-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease globally, and represents a health care burden as treatment options are very scarce. The reason behind the NAFLD progression to non-alcoholic steatohepatitis (NASH) is not completely understood. Recently, the deficiency of micronutrients (e.g., vitamins, minerals, and other elements) has been suggested as crucial in NAFLD progression, such that recent studies reported the potential hepatic antioxidant properties of micronutrients supplementation. However, very little is known. Here we have explored the potential beneficial effects of dietary supplementation with FLINAX, a novel mixture of nutraceuticals (i.e., vitamin E, vitamin D3, olive dry-extract, cinnamon dry-extract and fish oil) in a NAFLD model characterized by oxidative stress and mitochondrial function impairment. Steatosis was firstly induced in Wistar rats by feeding with a high-fat/high-cholesterol diet for 4 weeks, and following this the rats were divided into two groups. One group (n = 8) was treated for 2 weeks with a normal chow-diet, while a second group (n = 8) was fed with a chow-diet supplemented with 2% FLINAX. Along with the entire experiment (6 weeks), a third group of rats was fed with a chow-diet only as control. Statistical analysis was performed with Student’s T test or one-way ANOVA followed by post-hoc Bonferroni test when appropriate. Steatosis, oxidative stress and mitochondrial respiratory chain (RC) complexes activity were analyzed in liver tissues. The dietary supplementation with FLINAX significantly improved hepatic steatosis and lipid accumulation compared to untreated rats. The mRNA and protein levels analysis showed that <i>CPT1A</i> and <i>CPT2</i> were up-regulated by FLINAX, suggesting the enhancement of fatty acids oxidation (FAO). Important lipoperoxidation markers (i.e., HNE- and MDA-protein adducts) and the quantity of total mitochondrial oxidized proteins were significantly lower in FLINAX-treated rats. Intriguingly, FLINAX restored the mitochondrial function, stimulating the activity of mitochondrial RC complexes (i.e., I, II, III and ATP-synthase) and counteracting the peroxide production from pyruvate/malate (complex I) and succinate (complex II). Therefore, the supplementation with FLINAX reprogrammed the cellular energy homeostasis by restoring the efficiency of mitochondrial function, with a consequent improvement in steatosis.https://www.mdpi.com/2072-6643/13/2/652non-alcoholic fatty liver diseasenutraceuticalmitochondriamicronutrientssteatosisoxidative stress |
spellingShingle | Moris Sangineto Vidyasagar Naik Bukke Francesco Bellanti Rosanna Tamborra Archana Moola Loren Duda Rosanna Villani Antonino Davide Romano Gaetano Serviddio A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model Nutrients non-alcoholic fatty liver disease nutraceutical mitochondria micronutrients steatosis oxidative stress |
title | A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model |
title_full | A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model |
title_fullStr | A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model |
title_full_unstemmed | A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model |
title_short | A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model |
title_sort | novel nutraceuticals mixture improves liver steatosis by preventing oxidative stress and mitochondrial dysfunction in a nafld model |
topic | non-alcoholic fatty liver disease nutraceutical mitochondria micronutrients steatosis oxidative stress |
url | https://www.mdpi.com/2072-6643/13/2/652 |
work_keys_str_mv | AT morissangineto anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT vidyasagarnaikbukke anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT francescobellanti anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT rosannatamborra anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT archanamoola anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT lorenduda anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT rosannavillani anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT antoninodavideromano anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT gaetanoserviddio anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT morissangineto novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT vidyasagarnaikbukke novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT francescobellanti novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT rosannatamborra novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT archanamoola novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT lorenduda novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT rosannavillani novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT antoninodavideromano novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel AT gaetanoserviddio novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel |